These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22213544)

  • 21. Epitope mapping of gibberellin to the anti-gibberellin A(4) monoclonal antibody by saturation transfer difference NMR spectroscopy.
    Murata T; Hemmi H; Nakajima M; Yoshida M; Yamaguchi I
    Biochem Biophys Res Commun; 2003 Aug; 307(3):498-502. PubMed ID: 12893249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorinated carbohydrates as lectin ligands: versatile sensors in 19F-detected saturation transfer difference NMR spectroscopy.
    Diercks T; Ribeiro JP; Cañada FJ; André S; Jiménez-Barbero J; Gabius HJ
    Chemistry; 2009 Jun; 15(23):5666-8. PubMed ID: 19388026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Epitope Mapping by STD NMR Spectroscopy To Reveal the Nature of Protein-Ligand Contacts.
    Monaco S; Tailford LE; Juge N; Angulo J
    Angew Chem Int Ed Engl; 2017 Nov; 56(48):15289-15293. PubMed ID: 28977722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid protein-ligand costructures using chemical shift perturbations.
    Stark J; Powers R
    J Am Chem Soc; 2008 Jan; 130(2):535-45. PubMed ID: 18088118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [NMR in the fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
    [No Abstract]   [Full Text] [Related]  

  • 29. NMR studies of protein-ligand interactions.
    Maurer T
    Methods Mol Biol; 2005; 305():197-214. PubMed ID: 15939999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An account of NMR in structural biology.
    Wagner G
    Nat Struct Biol; 1997 Oct; 4 Suppl():841-4. PubMed ID: 9377155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution NMR of supramolecular complexes: providing new insights into function.
    Sprangers R; Velyvis A; Kay LE
    Nat Methods; 2007 Sep; 4(9):697-703. PubMed ID: 17762877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast time scale dynamics of protein backbones: NMR relaxation methods, applications, and functional consequences.
    Jarymowycz VA; Stone MJ
    Chem Rev; 2006 May; 106(5):1624-71. PubMed ID: 16683748
    [No Abstract]   [Full Text] [Related]  

  • 33. Binding Moiety Mapping by Saturation Transfer Difference NMR.
    Brender JR; Krishnamoorthy J; Ghosh A; Bhunia A
    Methods Mol Biol; 2018; 1824():49-65. PubMed ID: 30039401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saturation transfer difference NMR spectroscopy as a technique to investigate protein-carbohydrate interactions in solution.
    Haselhorst T; Lamerz AC; Itzstein Mv
    Methods Mol Biol; 2009; 534():375-86. PubMed ID: 19277538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How much NMR data is required to determine a protein-ligand complex structure?
    Schieborr U; Vogtherr M; Elshorst B; Betz M; Grimme S; Pescatore B; Langer T; Saxena K; Schwalbe H
    Chembiochem; 2005 Oct; 6(10):1891-8. PubMed ID: 16013076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of NMR to structure-based drug design in structural genomics.
    Powers R
    J Struct Funct Genomics; 2002; 2(2):113-23. PubMed ID: 12836668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein NMR-based screening in drug discovery.
    Zartler ER; Shapiro MJ
    Curr Pharm Des; 2006; 12(31):3963-72. PubMed ID: 17100607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.
    Angulo J; Enríquez-Navas PM; Nieto PM
    Chemistry; 2010 Jul; 16(26):7803-12. PubMed ID: 20496354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyl groups as probes for proteins and complexes in in-cell NMR experiments.
    Serber Z; Straub W; Corsini L; Nomura AM; Shimba N; Craik CS; Ortiz de Montellano P; Dötsch V
    J Am Chem Soc; 2004 Jun; 126(22):7119-25. PubMed ID: 15174883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quo vadis, virtual screening? A comprehensive survey of prospective applications.
    Ripphausen P; Nisius B; Peltason L; Bajorath J
    J Med Chem; 2010 Dec; 53(24):8461-7. PubMed ID: 20929257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.